Long intergenic non-protein coding RNA 507 (LINC00507)

Long intergenic non-protein coding RNA 507 (LINC00507) is a long non-coding RNA (lncRNA) transcript, mostly comprising >200 nucleotides and lacking significant protein-coding potential[2][7]. It belongs to the lincRNA subclass, which are characterized by their genomic positions between protein-coding genes and their tissue-specific expression. LINC00507 is notable for its highly specific and abundant expression in the primate cerebral cortex, displaying age-dependent patterns and cortical lamination[2][5][4]. Functional studies suggest a regulatory role in primate brain development and differentiation[2]; additionally, LINC00507 is implicated in Alzheimer’s disease by modulating the phosphorylation and accumulation of tau protein through interactions with miR-181c-5p, MAPT, and TTBK1[5]. There is evidence of potential micropeptide coding capacity, though further validation is needed[2]. LINC00507 is not currently considered a classic therapeutic drug target (such as a receptor, enzyme, or transporter), and there are no known drugs or mechanism-based therapies directly targeting this lncRNA[7]. Its major significance lies in its function as a regulatory RNA and a potential biomarker of neurodegenerative disease[5][10].

Other names

LINC00507linc00507Long intergenic non-protein coding RNA 507